Clinical Trials · NCT00123110

Insulin Resistance and Testosterone in Women

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University of Pennsylvania
Enrollment
35
Start date
Jul 2005
Locations
1 site, United States
Primary endpoint
Percent Change in Free Testosterone (T)
View Gonadorelin compound reference